<?xml version="1.0" encoding="UTF-8"?>
<p>In 2015, the UN General Assembly adopted Sustainable Development Goals (SDGs) relevant to HIV and HCV,
 <xref rid="bib11" ref-type="bibr">
  <sup>11</sup>
 </xref> including access to drug dependence treatment; targets for reductions in HIV and viral hepatitis incidence and prevalence; and access to essential medicines, including medicines used in OST (namely, methadone and buprenorphine).
 <xref rid="bib11" ref-type="bibr">11</xref>, 
 <xref rid="bib12" ref-type="bibr">12</xref> Additionally, the WHO Global Health Sector Strategy on Viral Hepatitis 2016â€“2021 includes harm reduction for PWID and HCV treatment as core interventions to eliminate viral hepatitis.
 <xref rid="bib13" ref-type="bibr">
  <sup>13</sup>
 </xref> There is clear recognition of the need to monitor progress towards these targets.
 <xref rid="bib11" ref-type="bibr">
  <sup>11</sup>
 </xref>
</p>
